Synthesis of novel lactam derivatives and their evaluation as ligands for the dopamine receptors, leading to a D4-selective ligand

被引:24
作者
Awadallah, Fadi M.
Mueller, Franziska
Lehmann, Jochen
Abadi, Ashraf H. [1 ]
机构
[1] German Univ Cairo, Fac Pharm & Biotechnol, Dept Pharmaceut Chem, Cairo, Egypt
[2] Univ Jena, Inst Pharm Pharmaceut Med Chem, D-6900 Jena, Germany
[3] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt
关键词
dopamine ligands; arylpiperazines; cyclic amides; lactams; receptor selectivity;
D O I
10.1016/j.bmc.2007.06.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The preparation of some lactam (cyclic amide) derivatives bearing various phenylpiperazinylbutyl side chains attached to the amide nitrogen together with their dopamine receptor affinity study is described. The synthesis of the target compounds involved the preparation of the intermediate bromobutyl derivatives of the appropriate lactam followed by N-alkylation of the appropriate phenylpiperazines with these intermediates. Radioligand binding studies at D-2-D5 receptor subtypes and a functional calcium assay of the target compounds at D-2 and D-5 receptor subtypes were performed. All compounds, except 12a and 12b, showed selectivity towards the D-2-like receptor subtypes. Selectivity of the indolinone derivatives 11 a-d at the D-4 receptors was observed. Compound 11b exhibited a remarkable affinity to hD(4) receptors with K-i value of 0.04 +/- 0.02 nm and was > 43,000-fold selective over the hD(2) receptor. In the functional assay, all the active compounds were of antagonistic activity. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5811 / 5818
页数:8
相关论文
共 22 条
[1]   Phenylpiperazinylmethylheterocycle derivatives: Synthesis and dopamine receptor binding profiles [J].
Abadi, AH .
ARCHIV DER PHARMAZIE, 2004, 337 (07) :383-390
[2]  
Audinot V, 1998, J PHARMACOL EXP THER, V287, P187
[3]   Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl) cyclohexane derivatives;: new, potent 5-HT1A receptor agents with anxiolytic-like activity [J].
Bojarski, AJ ;
Paluchowska, MH ;
Duszynska, B ;
Bugno, R ;
Klodzinska, A ;
Tatarczynska, E ;
Chojnacka-Wójcik, E .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (05) :1391-1402
[4]   Synthesis and pharmacological evaluation of new arylpiperazines.: 3-{4-[4-(3-chlorophenyl)-1-piperazinyl]butyl}-quinazolidin-4-one -: A dual serotonin 5-HT1A/5-HT2A receptor ligand with an anxiolytic-like activity [J].
Bojarski, AJ ;
Kowalski, P ;
Kowalska, T ;
Duszynska, B ;
Charakchieva-Minol, S ;
Tatarczynska, E ;
Klodzinska, A ;
Chojnacka-Wójcik, E .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (12) :3817-3827
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]  
CIVELLI O, 1993, ANNU REV PHARMACOL, V33, P281, DOI 10.1146/annurev.pa.33.040193.001433
[7]   Treatment of psychosis: 30 years of progress [J].
De Oliveira, I. R. ;
Juruena, M. F. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2006, 31 (06) :523-534
[8]   Dopamine receptor ligands. Part VII [1]: Novel 3-substituted 5-phenyl-1,2,3,4 5 6-hexahydro-azepino-[4 5-b]indoles as ligands for the dopamine receptors [J].
Decker, M ;
Lehmann, J .
ARCHIV DER PHARMAZIE, 2003, 336 (10) :466-476
[9]   Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder [J].
Dikeos, DG ;
Papadimitriou, GN ;
Avramopoulos, D ;
Karadima, G ;
Daskalopoulou, EG ;
Souery, D ;
Mendlewicz, J ;
Vassilopoulos, D ;
Stefanis, CN .
PSYCHIATRIC GENETICS, 1999, 9 (04) :189-195
[10]   Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats:: Role of dopamine D3 receptors [J].
Gilbert, JG ;
Newman, AH ;
Gardner, EL ;
Ashby, CR ;
Heidbreder, CA ;
Pak, AC ;
Peng, XQ ;
Xi, ZX .
SYNAPSE, 2005, 57 (01) :17-28